APON(SZ:300753) Xin Lang Cai Jing·2025-09-19 03:12Core Viewpoint - Aipeng Medical's stock has experienced significant fluctuations, with a year-to-date increase of 66.92% but a recent decline in the last five and twenty trading days [2] Group 1: Stock Performance - As of September 19, Aipeng Medical's stock price was 29.32 CNY per share, with a market capitalization of 3.696 billion CNY [1] - The stock has seen a decline of 5.08% over the last five trading days and 13.92% over the last twenty trading days [2] - Year-to-date, the stock has been on the龙虎榜 (top trading list) six times, with the most recent net buy of 11.9243 million CNY on August 8 [2] Group 2: Financial Performance - For the first half of 2025, Aipeng Medical reported a revenue of 159 million CNY, a year-on-year decrease of 11.31%, and a net profit of -19.3791 million CNY, a decrease of 317.90% [2] - Cumulative cash dividends since the A-share listing amount to 113 million CNY, with 16.3862 million CNY distributed over the last three years [3] Group 3: Company Overview - Aipeng Medical, established on October 30, 2001, specializes in the development, production, and sales of medical devices in pain management and nasal care [2] - The company's revenue composition includes 59.73% from pain management products, 29.40% from nasal and upper airway products, and 10.87% from other sources [2] - As of June 30, 2025, the number of shareholders increased by 57.18% to 32,400, while the average circulating shares per person decreased by 36.33% to 2,711 shares [2]